Literature DB >> 27995261

Interval increase in the prevalence of symptomatic cholelithiasis-associated non-alcoholic fatty liver disease over a ten-year period in an Asian population.

Kevin Beng Chin Khaw1, Rachel Huiyi Choi1, Juinn Huar Kam2, Bibhas Chakraborty3, Pierce Kah Hoe Chow2,3,4.   

Abstract

INTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is frequently associated with cholelithiasis. The prevalence of NAFLD in Asia has been on the rise, but the magnitude of this increase had not been studied previously.
METHODS: A retrospective cohort study was conducted on consecutive patients who underwent laparoscopic or open cholecystectomy from November 2001 to November 2004 (Cohort 1) and from November 2011 to November 2014 (Cohort 2) at Singapore General Hospital. Preoperative diagnostic scans (e.g. ultrasonography, computed tomography and magnetic resonance imaging) and clinical data were reviewed for the presence of fatty liver. Statistical analysis was performed.
RESULTS: In Cohorts 1 and 2, 127 patients and 99 patients were operated on, respectively. Cohort 2 had significantly higher proportions of patients with NAFLD (56.6% vs. 40.2%; p < 0.015) and hyperlipidaemia (45.5% vs. 18.9%; p < 0.001) as compared to Cohort 1. Binary logistic regression analysis showed that hypertension (odds ratio [OR] 2.558; p < 0.004) and Indian ethnicity (OR 5.448; p < 0.043) were significantly associated with NAFLD.
CONCLUSION: Similar to other international studies, we found a significant increase in the prevalence of patients with NAFLD presenting symptomatically for cholecystectomy over an interval of ten years in Singapore. Hypertension and Indian ethnicity were significantly associated with NAFLD in both time periods. This trend supports the need for concerted public health intervention to stem the increasing incidence of NAFLD and prevent its progression to more advanced liver disease. Copyright: © Singapore Medical Association

Entities:  

Keywords:  Asian; Singapore; cholelithiasis; epidemiology; non-alcoholic fatty liver disease

Mesh:

Year:  2016        PMID: 27995261      PMCID: PMC5917056          DOI: 10.11622/smedj.2016189

Source DB:  PubMed          Journal:  Singapore Med J        ISSN: 0037-5675            Impact factor:   1.858


  24 in total

Review 1.  The global NAFLD epidemic.

Authors:  Rohit Loomba; Arun J Sanyal
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-09-17       Impact factor: 46.802

Review 2.  Pathogenesis of cholesterol and pigment gallstones: an update.

Authors:  Karel Johannes Van Erpecum
Journal:  Clin Res Hepatol Gastroenterol       Date:  2011-02-25       Impact factor: 2.947

3.  Non-alcoholic fatty liver disease in a young multiracial Asian population: a worrying ethnic predilection in Malay and Indian males.

Authors:  Wah-Kheong Chan; Norhaniza Bahar; Hamizah Razlan; Anushya Vijayananthan; Pavai Sithaneshwar; Khean-Lee Goh
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

4.  Gallstone disease in non-alcoholic fatty liver: prevalence and associated factors.

Authors:  Paola Loria; Amedeo Lonardo; Silvia Lombardini; Lucia Carulli; Annamaria Verrone; Dorval Ganazzi; Antonia Rudilosso; Roberto D'Amico; Marco Bertolotti; Nicola Carulli
Journal:  J Gastroenterol Hepatol       Date:  2005-08       Impact factor: 4.029

5.  Sex and race differences in fat distribution among Asian, African-American, and Caucasian prepubertal children.

Authors:  Qing He; Mary Horlick; John Thornton; Jack Wang; Richard N Pierson; Stanley Heshka; Dympna Gallagher
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

Review 6.  Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment.

Authors:  Briohny W Smith; Leon A Adams
Journal:  Nat Rev Endocrinol       Date:  2011-05-10       Impact factor: 43.330

Review 7.  NAFLD in Asia--as common and important as in the West.

Authors:  Geoffrey C Farrell; Vincent Wai-Sun Wong; Shiv Chitturi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2013-03-05       Impact factor: 46.802

Review 8.  Nonalcoholic fatty liver disease and cholesterol gallstones: which comes first?

Authors:  Mohamed H Ahmed; Asif Ali
Journal:  Scand J Gastroenterol       Date:  2014-03-20       Impact factor: 2.423

9.  Ezetimibe: its novel effects on the prevention and the treatment of cholesterol gallstones and nonalcoholic Fatty liver disease.

Authors:  Ornella de Bari; Brent A Neuschwander-Tetri; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  J Lipids       Date:  2011-11-03

10.  Clinical predictors of incident gallstone disease in a Chinese population in Taipei, Taiwan.

Authors:  Jau-Yuan Chen; Chung-Te Hsu; Jorn-Hon Liu; Tao-Hsin Tung
Journal:  BMC Gastroenterol       Date:  2014-04-28       Impact factor: 3.067

View more
  4 in total

1.  Triglycerides Mediate Body Mass Index and Nonalcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Jie Xing; Xue Guan; Qian Zhang; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Obes Facts       Date:  2021-03-29       Impact factor: 3.942

Review 2.  Liver diseases in the Asia-Pacific region: a Lancet Gastroenterology & Hepatology Commission.

Authors:  Shiv K Sarin; Manoj Kumar; Mohammed Eslam; Jacob George; Mamun Al Mahtab; Sheikh M Fazle Akbar; Jidong Jia; Qiuju Tian; Rakesh Aggarwal; David H Muljono; Masao Omata; Yoshihiko Ooka; Kwang-Hyub Han; Hye Won Lee; Wasim Jafri; Amna S Butt; Chern H Chong; Seng G Lim; Raoh-Fang Pwu; Ding-Shinn Chen
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-12-15

3.  Systolic Blood Pressure Mediates Body Mass Index and Non-alcoholic Fatty Liver Disease: A Population-Based Study.

Authors:  Xue Guan; Qian Zhang; Jie Xing; Shuohua Chen; Shouling Wu; Xiujing Sun
Journal:  Turk J Gastroenterol       Date:  2021-05       Impact factor: 1.852

Review 4.  Liver Disease in Singapore.

Authors:  Mark Muthiah; Chern H Chong; Seng G Lim
Journal:  Euroasian J Hepatogastroenterol       Date:  2018-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.